Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Terry D Heiman-Patterson

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Continuum (Minneapolis, Minn.)|October 18, 2023
Multidisciplinary Clinics in Neuromuscular MedicineKelly Gwathmey, Terry D Heiman-Patterson
Neurology|September 13, 2006
NIPPV: a treatment for ALS whose time has comeTerry D Heiman-Patterson, Robert G Miller
Neurology|January 30, 2025
Health Care Delivery and Financial Considerations in Amyotrophic Lateral Sclerosis Clinics: A Survey of Clinic DirectorsIlene L Hollin, Gema Giler, Terry D Heiman-Patterson, et al.
Journal of the Neurological Sciences|January 16, 2002
GLT-1 glutamate transporter levels are unchanged in mice expressing G93A human mutant SOD1Jeffrey S Deitch, Guillermo M Alexander, Luis Del Valle, et al.
Plos One|June 20, 2014
Phenotype of transgenic mice carrying a very low copy number of the mutant human G93A superoxide dismutase-1 gene associated with amyotrophic lateral sclerosisJeffrey S Deitch, Guillermo M Alexander, Andrew Bensinger, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|August 5, 2021
Use of a new ALS specific respiratory questionnaire: the ARES scoreTerry D Heiman-Patterson, Michael S Sherman, Daohai Yu, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|August 5, 2021
Pulmonary function decline in amyotrophic lateral sclerosisTerry D Heiman-Patterson, Ossama Khazaal, Daohai Yu, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|June 24, 2020
Real-world evidence of riluzole effectiveness in treating amyotrophic lateral sclerosisJinsy A Andrews, Carlayne E Jackson, Terry D Heiman-Patterson, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|July 11, 2014
A major QTL on mouse chromosome 17 resulting in lifespan variability in SOD1-G93A transgenic mouse models of amyotrophic lateral sclerosisRoger B Sher, Terry D Heiman-Patterson, Elizabeth A Blankenhorn, et al.
Brain Research. Molecular Brain Research|November 3, 2004
Effect of transgene copy number on survival in the G93A SOD1 transgenic mouse model of ALSGuillermo M Alexander, Kirsten L Erwin, Nathaniel Byers, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Continuum (Minneapolis, Minn.)|October 18, 2023
Multidisciplinary Clinics in Neuromuscular MedicineKelly Gwathmey, Terry D Heiman-Patterson
Neurology|September 13, 2006
NIPPV: a treatment for ALS whose time has comeTerry D Heiman-Patterson, Robert G Miller
Neurology|January 30, 2025
Health Care Delivery and Financial Considerations in Amyotrophic Lateral Sclerosis Clinics: A Survey of Clinic DirectorsIlene L Hollin, Gema Giler, Terry D Heiman-Patterson, et al.
Journal of the Neurological Sciences|January 16, 2002
GLT-1 glutamate transporter levels are unchanged in mice expressing G93A human mutant SOD1Jeffrey S Deitch, Guillermo M Alexander, Luis Del Valle, et al.
Plos One|June 20, 2014
Phenotype of transgenic mice carrying a very low copy number of the mutant human G93A superoxide dismutase-1 gene associated with amyotrophic lateral sclerosisJeffrey S Deitch, Guillermo M Alexander, Andrew Bensinger, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|August 5, 2021
Use of a new ALS specific respiratory questionnaire: the ARES scoreTerry D Heiman-Patterson, Michael S Sherman, Daohai Yu, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|August 5, 2021
Pulmonary function decline in amyotrophic lateral sclerosisTerry D Heiman-Patterson, Ossama Khazaal, Daohai Yu, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|June 24, 2020
Real-world evidence of riluzole effectiveness in treating amyotrophic lateral sclerosisJinsy A Andrews, Carlayne E Jackson, Terry D Heiman-Patterson, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|July 11, 2014
A major QTL on mouse chromosome 17 resulting in lifespan variability in SOD1-G93A transgenic mouse models of amyotrophic lateral sclerosisRoger B Sher, Terry D Heiman-Patterson, Elizabeth A Blankenhorn, et al.
Brain Research. Molecular Brain Research|November 3, 2004
Effect of transgene copy number on survival in the G93A SOD1 transgenic mouse model of ALSGuillermo M Alexander, Kirsten L Erwin, Nathaniel Byers, et al.
Pageof 3